COLLPLANT BIOTECHNOLOGIES LT (CLGN) Stock Cash Flow
NASDAQ:CLGN - Nasdaq - IL0004960188 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -17.42M | -7.02M | -16.93M | 240.00K | -5.77M | |||
| Depreciation Amortization | 1.08M | 1.10M | 1.08M | 770.00K | 660.00K | |||
| Change In Working Capital | 1.48M | 820.00K | -540.00K | 220.00K | -1.12M | |||
| Other non cash items | 1.89M | 2.33M | 2.70M | 1.28M | 1.79M | |||
| OPERATING CASH FLOW | -12.97M | -2.76M | -13.70M | 2.50M | -4.45M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -653.00K | -954.00K | -1.32M | -1.59M | -520.00K | |||
| Other Investing Activity | N/A | -202.00K | 30.24M | -29.97M | 0.00 | |||
| INVESTING CASH FLOW | -853.00K | -1.16M | 28.92M | -31.56M | -520.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 0.00 | -20.00K | |||
| Stock Issued/Repurchased | 9.00K | 1.11M | 1.87M | 38.76M | 4.49M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | N/A | |||
| FINANCING CASH FLOW | 9.00K | 1.11M | 1.87M | 38.76M | 4.47M | |||
| Exchange Rate Effect | -3.00K | -379.00K | -610.00K | 140.00K | 60.00K | |||
| CHANGE IN CASH | -13.82M | -3.19M | 16.48M | 9.84M | -440.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -12.97M | -2.76M | -13.70M | 2.50M | -4.45M | |||
| Capital Expenditure | -653.00K | -954.00K | -1.32M | -1.59M | -520.00K | |||
| FREE CASH FLOW | -13.63M | -3.72M | -15.02M | 910.00K | -4.97M | |||
All data in USD